Breaking News Instant updates and real-time market news.

JAZZ

Jazz Pharmaceuticals

$179.32

-0.67 (-0.37%)

, AMRX

Amneal Pharmaceuticals

$18.34

0.27 (1.49%)

09:39
07/13/18
07/13
09:39
07/13/18
09:39

Amneal wins patent challenge against Jazz Pharmaceuticals' Xyrem, Bloomberg says

An appeals court found that seven Jazz (JAZZ) patents being challenged by Amneal Pharmaceuticals (AMRX) are invalid, according to Bloomberg.

JAZZ

Jazz Pharmaceuticals

$179.32

-0.67 (-0.37%)

AMRX

Amneal Pharmaceuticals

$18.34

0.27 (1.49%)

  • 09

    Aug

  • 27

    Oct

  • 20

    Dec

JAZZ Jazz Pharmaceuticals
$179.32

-0.67 (-0.37%)

07/11/18
07/11/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Steven Madden (SHOO) downgraded to Neutral from Outperform at Wedbush with analyst Christopher Svezia citing valuation. 2. Jazz Pharmaceuticals (JAZZ) downgraded to Equal Weight at Morgan Stanley with analyst David Risinger saying he believes potential M&A could add new growth drivers and diversify Jazz from Xyrem, which is expected to represent about 70% of its FY18 revenue, but Risinger also thinks investors already anticipate action on that front. 3. U.S. Cellular (USM) and Telephone and Data (TDS) were downgraded to Underweight from Neutral at JPMorgan. 4. Hess Corp. (HES) downgraded to Underweight from Equal Weight at Barclays with analyst Paul Cheng saying his analysis indicates Hess trades at the "steepest premium" in the group. 5. Westlake Chemical (WLK) downgraded to Neutral from Buy at Nomura Instinet with analyst Aleksey Yefremov saying he expects softer demand to weigh on cyclical stocks and reduced his estimates for seven names in the Americas Chemicals space. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
07/11/18
07/11/18
DOWNGRADE
Target $183

Equal Weight
Jazz Pharmaceuticals downgraded to Equal Weight after rally at Morgan Stanley
As previously reported, Morgan Stanley analyst David Risinger downgraded Jazz Pharmaceuticals to Equal Weight from Overweight as a rally in the stock has brought it to a closing price on Tuesday of $180.57, which is approaching his unchanged price target of $183. He believes potential M&A could add new growth drivers and diversify Jazz from Xyrem, which is expected to represent about 70% of its FY18 revenue, but Risinger also thinks investors already anticipate action on that front.
07/11/18
MSCO
07/11/18
DOWNGRADE
MSCO
Equal Weight
Jazz Pharmaceuticals downgraded to Equal Weight at Morgan Stanley
07/10/18
SBSH
07/10/18
NO CHANGE
Target $205
SBSH
Buy
Jazz Pharmaceuticals price target raised to $205 from $162 at Citi
Citi analyst Liav Abraham raised her price target for Jazz Pharmaceuticals to $205 and keeps a Buy rating on the shares. The analyst remains a constructive stance on Jazz given the potential for upside to consensus estimates. Further, balance sheet optionality can support business development and drive revenue diversification, Abraham tells investors in a research note. The analyst also has increased confidence in the commercial opportunity for solriamfetol.
AMRX Amneal Pharmaceuticals
$18.34

0.27 (1.49%)

06/22/18
RILY
06/22/18
INITIATION
Target $26
RILY
Buy
Amneal Pharmaceuticals initiated with a Buy at B. Riley FBR
B. Riley FBR analyst David Buck started Amneal Pharmaceuticals with a Buy rating and $26 price target. The merger of two niche generic companies created a new generic leader, Buck tells investors in a research note.
05/18/18
05/18/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. MasterCard (MA) initiated with a Neutral at UBS. 2. AMD (AMD) initiated with an Outperform at Cowen while Intel (INTC) was initiated with a Market Perform. 3. Synthetic Biologics (SYN) initiated with a Buy at H.C. Wainwright. 4. Amneal Pharmaceuticals (AMRX) initiated with a Neutral at JPMorgan. 5. Apollo Commercial (ARI) initiated with a Buy at Deutsche Bank. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
05/18/18
JPMS
05/18/18
INITIATION
Target $18
JPMS
Neutral
Amneal Pharmaceuticals initiated with a Neutral at JPMorgan
JPMorgan analyst Chris Schott started Amneal Pharmaceuticals with a Neutral rating and $18 price target. The company is well positioned within the generics space, but its valuation trades at a premium to peers, Schott tells investors in a research note. He also notes the company's 2018 guidance requires a "significant step up" in EBITDA from Q1 levels based on a heavy cycle of upcoming pipeline launches.
05/09/18
05/09/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Cleveland-Cliffs (CLF) initiated with a Buy at Seaport Global. 2. Amneal Pharmaceuticals (AMRX) initiated with a Buy at Deutsche Bank. 3. Iridium (IRDM) initiated with a Buy at BWS Financial. 4. ServiceMaster (SERV) initiated with a Buy at Buckingham while Rollins (ROL) was initiated with a Neutral at Buckingham. 5. Eiger BioPharmaceuticals (EIGR) initiated with a Buy at B. Riley FBR. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.

TODAY'S FREE FLY STORIES

ABT

Abbott

$68.72

-0.62 (-0.89%)

17:19
10/15/18
10/15
17:19
10/15/18
17:19
Initiation
Abbott initiated  »

Abbott initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

SBBX

SB One Bancorp

$24.00

-0.27 (-1.11%)

17:19
10/15/18
10/15
17:19
10/15/18
17:19
Hot Stocks
Breaking Hot Stocks news story on SB One Bancorp »

EJF Capital reports 5.5%…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HQCL

Hanwah Q Cells

$8.20

-0.13 (-1.56%)

17:07
10/15/18
10/15
17:07
10/15/18
17:07
Hot Stocks
Hanwah Q Cells up 8.5% after agreeing to be acquired by Hanwha Solar »

In after-hours trading,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MBRX

Moleculin Biotech

$1.38

-0.005 (-0.36%)

17:06
10/15/18
10/15
17:06
10/15/18
17:06
Syndicate
Breaking Syndicate news story on Moleculin Biotech »

Moleculin Biotech files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CRY

CryoLife

$30.64

0.42 (1.39%)

17:04
10/15/18
10/15
17:04
10/15/18
17:04
Earnings
CryoLife reports preliminary Q3 revenue $64.6M, consensus $61.84M »

Preliminary and unaudited…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TRQ

Turquoise Hill

$1.96

-0.015 (-0.76%)

, RIO

Rio Tinto

$49.54

0.34 (0.69%)

17:03
10/15/18
10/15
17:03
10/15/18
17:03
Hot Stocks
Turquoise Hill provides underground development update »

Turquoise Hill (TRQ)…

TRQ

Turquoise Hill

$1.96

-0.015 (-0.76%)

RIO

Rio Tinto

$49.54

0.34 (0.69%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PANW

Palo Alto Networks

$209.49

-2.51 (-1.18%)

17:02
10/15/18
10/15
17:02
10/15/18
17:02
Earnings
Palo Alto Networks backs Q1 EPS view $1.04-$1.06, consensus $1.06 »

Backs Q1 revenue view of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

  • 10

    Dec

TRQ

Turquoise Hill

$1.96

-0.015 (-0.76%)

17:01
10/15/18
10/15
17:01
10/15/18
17:01
Hot Stocks
Turquoise Hil reports Q3 throughput down 5% y/y »

Turquoise Hill Resources…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HQCL

Hanwah Q Cells

$8.20

-0.13 (-1.56%)

17:01
10/15/18
10/15
17:01
10/15/18
17:01
Hot Stocks
Breaking Hot Stocks news story on Hanwah Q Cells »

Hanwha Q CELLS trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PANW

Palo Alto Networks

$209.49

-2.51 (-1.18%)

17:00
10/15/18
10/15
17:00
10/15/18
17:00
Hot Stocks
Palo Alto Networks names Amit Singh as President »

Palo Alto Networks…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

  • 10

    Dec

BCOR

Blucora

$32.96

-0.23 (-0.69%)

16:59
10/15/18
10/15
16:59
10/15/18
16:59
Hot Stocks
Blucora names Tran Taylor chief HR officer »

Blucora announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FB

Facebook

$153.56

-0.2 (-0.13%)

16:56
10/15/18
10/15
16:56
10/15/18
16:56
Periodicals
Facebook to ban false information on voting ahead of midterms, Reuters says »

Facebook plans to ban…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Oct

  • 30

    Oct

  • 07

    Nov

ADBE

Adobe

$238.05

-10.84 (-4.36%)

16:55
10/15/18
10/15
16:55
10/15/18
16:55
Conference/Events
Adobe to host financial analyst meeting »

Financial Analyst Meeting…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Oct

LDOS

Leidos

$66.00

0.91 (1.40%)

16:50
10/15/18
10/15
16:50
10/15/18
16:50
Hot Stocks
Leidos achieves CMMI Level 3 for Development »

Leidos announced that the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Oct

AGN

Allergan

$183.03

-0.275 (-0.15%)

, ACRS

Aclaris Therapeutics

$13.38

-0.21 (-1.55%)

16:50
10/15/18
10/15
16:50
10/15/18
16:50
Conference/Events
Aclaris Therapeutics to host conference call »

Conference call to…

AGN

Allergan

$183.03

-0.275 (-0.15%)

ACRS

Aclaris Therapeutics

$13.38

-0.21 (-1.55%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Oct

  • 30

    Oct

  • 27

    Nov

SEND

SendGrid

$30.94

0.04 (0.13%)

16:47
10/15/18
10/15
16:47
10/15/18
16:47
Hot Stocks
Breaking Hot Stocks news story on SendGrid »

SendGrid spikes up over…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TWLO

Twilio

$76.26

1.27 (1.69%)

, SEND

SendGrid

$30.94

0.04 (0.13%)

16:45
10/15/18
10/15
16:45
10/15/18
16:45
Hot Stocks
Twilio to acquire SendGrid for $2B or $36.92 per share in all-stock deal »

Twilio (TWLO) and…

TWLO

Twilio

$76.26

1.27 (1.69%)

SEND

SendGrid

$30.94

0.04 (0.13%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

HQCL

Hanwah Q Cells

$8.20

-0.13 (-1.56%)

16:45
10/15/18
10/15
16:45
10/15/18
16:45
Hot Stocks
Hanwah Q Cells to be acquired by Hanwha Solar for ~ $825M equity value »

Hanwha Q CELLS announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TGE

Tallgrass Energy

$23.73

0.17 (0.72%)

16:45
10/15/18
10/15
16:45
10/15/18
16:45
Hot Stocks
Tallgrass Energy increases quarterly dividend 2.5% »

Tallgrass Energy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WAGE

WageWorks

$41.55

0.42 (1.02%)

16:42
10/15/18
10/15
16:42
10/15/18
16:42
Hot Stocks
WageWorks appoints Ismail Dawood as CFO »

The board of WageWorks…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

COT

Cott Corp.

$14.80

-0.05 (-0.34%)

16:37
10/15/18
10/15
16:37
10/15/18
16:37
Hot Stocks
Cott Corp. subsidiary acquires Mountain Valley for $78.5M »

Cott Corp. announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Nov

EBS

Emergent BioSolutions

$60.47

-0.4 (-0.66%)

16:36
10/15/18
10/15
16:36
10/15/18
16:36
Hot Stocks
Emergent BioSolutions completes Adapt Pharma acquisition »

Emergent BioSolutions …

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Nov

EIGR

Eiger BioPharmaceuticals

$10.25

0.05 (0.49%)

16:35
10/15/18
10/15
16:35
10/15/18
16:35
Hot Stocks
Breaking Hot Stocks news story on Eiger BioPharmaceuticals »

683 Capital reports 5.9%…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

RPD

Rapid7

$33.33

-0.59 (-1.74%)

16:33
10/15/18
10/15
16:33
10/15/18
16:33
Hot Stocks
Rapid7 acquires tCell.io, terms not disclosed »

Rapid7, Inc. announced it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

  • 06

    Nov

  • 13

    Nov

KALU

Kaiser Aluminum

$102.46

1.04 (1.03%)

16:32
10/15/18
10/15
16:32
10/15/18
16:32
Hot Stocks
Kaiser Aluminum authorizes additional $100M for share repurchases »

The Board of Directors…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.